89bio ETNB

$ 7.99 0.13%

Quarterly report 2024-Q3
added 11-07-2024

89bio Financial Statements 2011-2024 | ETNB

Annual Financial Statements 89bio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	902 M	441 M	118 M	47.6 M	71.2 M	-	-	-	-	-	-	-	-
Shares	71.2 M	34.8 M	20.1 M	2.34 M	2.34 M	-	-	-	-	-	-	-	-
Historical Prices	12.7	12.7	5.89	20.3	26.7	-	-	-	-	-	-	-	-
Net Income	-142 M	-102 M	-90.1 M	-49.5 M	-57.4 M	-16.2 M	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-151 M	-102 M	-89.7 M	-49.4 M	-26.6 M	-15.2 M	-	-	-	-	-	-	-
Interest Expense	4.79 M	1.92 M	674 K	-203 K	-30.6 M	-986 K	-	-	-	-	-	-	-
EBITDA	-151 M	-102 M	-89.7 M	-49.3 M	-26.6 M	-15.2 M	-	-	-	-	-	-	-
Operating Expenses	151 M	102 M	89.7 M	49.4 M	26.6 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	29 M	21.5 M	19.4 M	13.2 M	5.29 M	1.48 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement 89bio

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	107 M	99.8 M	95.8 M	93.3 M	76.3 M	74.1 M	53.2 M	-	47.3 M	20.4 M	20.3 M	20.3 M	20.1 M	20.1 M	20 M	19.9 M	16.9 M	13.8 M	13.8 M	13.8 M	611 K	611 K	611 K	611 K	611 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-149 M	-48 M	-51.7 M	-	-34.7 M	-38.4 M	-28.8 M	-	-26.8 M	-25.1 M	-25.6 M	-	-28.3 M	-20.7 M	-14.8 M	-	-14.6 M	-11.8 M	-10.5 M	-19.3 M	-18.7 M	-15 M	-4.44 M	-4.64 M	-4.16 M	-7.37 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-152 M	-53.4 M	-57.3 M	-	-39.3 M	-42.1 M	-28.5 M	-	-27 M	-24.7 M	-25.1 M	-	-28.2 M	-20.6 M	-14.7 M	-	-14.4 M	-11.7 M	-10.7 M	-9.61 M	8.2 M	4 M	-4.83 M	-4.41 M	-3.79 M	-6.97 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	2.36 M	874 K	863 K	-	959 K	894 K	2.08 M	-	535 K	434 K	-456 K	-	-117 K	-172 K	-43 K	-	-146 K	-98 K	157 K	-	10.5 M	11 M	416 K	-	-379 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-57.3 M	-	-	-	-28.5 M	-	-27 M	-24.7 M	-25.1 M	-	-28.2 M	-20.5 M	-14.7 M	-	-14.4 M	-11.6 M	-10.7 M	-9.61 M	8.21 M	4.01 M	-4.83 M	-4.41 M	-3.78 M	-6.97 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	152 M	53.4 M	57.3 M	-	39.3 M	42.1 M	28.5 M	-	27 M	24.7 M	25.1 M	-	28.2 M	20.6 M	14.7 M	-	14.4 M	11.7 M	10.7 M	-	8.2 M	4 M	4.83 M	-	3.79 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	10.5 M	8.57 M	9.85 M	-	7.93 M	7.21 M	6.22 M	-	4.84 M	5.05 M	5.26 M	-	4.62 M	4.92 M	4.61 M	-	3.22 M	3.23 M	2.92 M	-	1.52 M	834 K	523 K	-	497 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency